274
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Comparison of Enhanced Depth Imaging and Swept Source Optical Coherence Tomography in Assessment of Choroidal Thickness in Vogt–Koyanagi–Harada Disease

, FRCOphth, , MBBS & , FRCS
Pages 528-532 | Received 29 Jul 2015, Accepted 04 Feb 2016, Published online: 12 Apr 2016

REFERENCES

  • Chee SP, Jap A, Bacsal K. Spectrum of Vogt–Koyanagi–Harada disease in Singapore. Int Ophthalmol. 2007;27:137–142.
  • Jap A, Luu CD, Yeo I, et al. Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt–Koyanagi–Harada disease. Eye (Lond). 2008;22:240–245.
  • Chee SP, Luu CD, Cheng CL, et al. Visual function in Vogt–Koyanagi–Harada patients. Graefes Arch Clin Exp Ophthalmol. 2005;243:785–790.
  • Sonoda S, Nakao K, Ohba N. Extensive chorioretinal atrophy in Vogt–Koyanagi–Harada disease. Jpn J Ophthalmol. 1999;43:113–119.
  • Nakayama M, Keino H, Okada AA, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt–Koyanagi–Harada disease. Retina. 2012;32:2061–2069.
  • Nakai K, Gomi F, Ikuno Y, et al. Choroidal observations in Vogt–Koyanagi–Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250:1089–1095.
  • Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt–Koyanagi–Harada disease. Retina. 2011;31:502–509.
  • Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt–Koyanagi–Harada disease. Retina. 2011;31:510–517.
  • da Silva FT, Sakata VM, Nakashima A, et al. Enhanced depth imaging optical coherence tomography in long-standing Vogt–Koyanagi–Harada disease. Br J Ophthalmol. 2013;97:70–74.
  • Takahashi H, Takase H, Ishizuka A, et al. Choroidal thickness in convalescent Vogt–Koyanagi–Harada disease. Retina. 2014;34:775–780.
  • Copete S, Flores-Moreno I, Montero JA, et al. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br J Ophthalmol. 2014;98:334–338.
  • Adhi M, Liu JJ, Qavi AH, et al. Enhanced visualization of the choroido-scleral interface using swept-source OCT. Ophthalmic Surg Lasers Imaging Retina. 2013;44(6 Suppl):S40–S42.
  • Lim LS, Cheung G, Lee SY. Comparison of spectral domain and swept-source optical coherence in pathological myopia. Eye (Lond). 2014;28:488–491.
  • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652.
  • Wei WB, Xu L, Jonas, et al. Subfoveal choroidal thickness: the Beijing Eye Study. Ophthalmology. 2013;120:175–180.
  • Usui S, Ikuno Y, Akiba M, et al. Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci. 2012;53:2300–2307.
  • Tan CS, Ouyang Y, Ruiz H, et al. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53:261–266.
  • Toyokawa N, Kimura H, Fukomoto A, et al. Difference in morning and evening choroidal thickness in Japanese subjects with no chorioretinal disease. Ophthalmic Surg Lasers Imaging. 2012;43:109–114.
  • Motaghiannezam R, Schwartz DM, Fraser SE. In vivo human choroidal vascular pattern visualization using high-speed swept-source optical coherence tomography at 1060 nm. Invest Ophthalmol Vis Sci. 2012;53:2337–2348.
  • Motaghiannezam SM, Koos D, Fraser SE. Differential phase-contrast, swept-source optical coherence tomography at 1060 nm for in vivo human retinal and choroidal vasculature visualization. J Biomed Opt. 2012;17:026011.
  • Kawaguchi T, Horie S, Bouchenaki N, et al. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt–Koyanagi–Harada disease. Int Ophthalmol. 2010;30:41–50.
  • Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt–Koyanagi–Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol. 2007;27:173–182.
  • Vasconcelos-Santos DV, Sohn EH, Sadda S, et al. Retinal pigment epithelial changes in chronic Vogt–Koyanagi–Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings. Retina. 2010;30:33–41.
  • Ayata A, Dogru S, Senol MG, et al. Autofluorescence findings in Vogt–Koyanagi–Harada disease. Eur J Ophthalmol. 2009;19:1094–1097.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.